Atrial fibrillation (AF) and chronic kidney disease (CKD) are strictly related; several
independent risk factors of AF are often frequent in CKD patients. AF prevalence is very …

Atrial fibrillation (AF) is highly prevalent among patients with chronic kidney disease (CKD),
and also associated with unfavorable outcome. Anticoagulant therapy is the mainstep of …

The frequent coexistence in daily clinical practice of chronic kidney disease (CKD) and atrial
fibrillation (AF), especially in the elderly, represents a conundrum for physicians, mainly …

Atrial fibrillation (AF) and chronic kidney disease (CKD) are increasingly prevalent in the
general population and share common risk factors such as older age, hypertension and …

Atrial fibrillation (AF) represents the most common arrhythmia in patients with chronic kidney
disease (CKD). As in the general population, in CKD patients AF is associated with an …

Both atrial fibrillation (AF) and chronic kidney disease (CKD) are highly prevalent, especially
with increasing age and associated comorbidities, such as hypertension, diabetes, heart …

Atrial fibrillation (AF) is the most frequent arrhythmia in common clinical practice and its
prevalence is markedly increased among patients with chronic kidney disease (CKD). The …

Background Patients with atrial fibrillation (AF) and chronic kidney disease (CKD) are at high
risk for both thromboembolism and bleeding events. The latter induces a potential reason for …

Background The prevalence of atrial fibrillation (AF) in individuals with end-stage renal
disease (ESRD) on chronic hemodialysis is increasing. The optimal anticoagulant choice in …

Atrial fibrillation (AF) is a frequent comorbid condition in patients with end‐stage renal
disease on hemodialysis (HD) with a prevalence of up to 27%. The incidence rate of stroke …